As of May 27
| +0.21 / +3.98%|
The 3 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 12.00, with a high estimate of 13.00 and a low estimate of 12.00. The median estimate represents a +118.58% increase from the last price of 5.49.
The current consensus among 3 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.